期刊文献+

阿托伐他汀对心肌纤维化影响的实验研究及其作用机制 被引量:6

Experimental study on the effects of atorvastatin in myocardial fibrosis and its effective machanisms
原文传递
导出
摘要 目的研究心肌纤维化时NAD(P)H氧化酶与转化生长因子(TGF)-β1、结缔组织生长因子(CTGF)的关系以及阿托伐他汀对心肌纤维化的作用。方法用两肾两夹法建立肾性高血压模型。给予阿托伐他汀10,5 mg·kg-1·d-1和坎地沙坦10 mg·kg-1·d-1,连续4周后,检测血流动力学参数、左心室/体重比率(LVW/BW);Masson染色检测心肌纤维化程度;Western-blot检测Nox4、TGF-β1和CTGF的表达。结果阿托伐他汀显著改善了高血压大鼠的心功能障碍和心肌纤维化程度,并且显著下调了Nox4、TGF-β1和CTGF在心肌组织的表达。结论阿托伐他汀能降低高血压大鼠心肌纤维化程度及改善心功能,其机制与抑制TGF-β1/Nox4/CTGF通路有关。 Objective To investigate the effect of the atorvastatin in the myocardial fibrosis and study the relationship of Nox 4 and connective tis-sue growth factor ( CTGF ) .Methods The two -kidney two -clip (2K2C) method was used to induce renovascular hypertension.After ator-vastatin (10, 5 mg· kg-1 · d-1 ) and candesartan (10 mg· kg -1 · d-1 ) were given for 4 weeks, hemodynamic parameters were measured and left ventricular weight to body weight ( LVW/BW) ratio was calculated.Mor-phological analysis was performed by using Masson staining.Western -blot was used to investigate the expression of Nox 4 , transforming growth factor(TGF) -β1 and CTGF in left ventricle ( LV).Results Aortic systolic pressure ( AoSP) ,aortic diastolic pressure ( AoDP) ,left ventricu-lar end-systolic pressure (LVESP),left ventricular end-diastolic pres-sure ( LVEDP) and LVW/BW ratio were markedly elevated while maxi-mum ascending rate of left ventricular pressure (+dp/dtmax ) and maxi-mum declining rate of left ventricular ( -dp/dtmax ) were significantly decreased in 2K2C rats.Atorvastatin or candesartan could prevente the decrease in +dp/dtmax or -dp/dtmax, however, atorvastatin had no significant blood -lowing effects.LVW/BW ratio and left ventricular perivascular collagen fraction ( PCVF ) increased significantly in hyper-tension rats.Both atorvastatin and candesartan partly reversed these effects and improved the cardiac hypertrophy and fibrosis.The expressionof Nox4, TGF-β1 and CTGF increased significantly in LV of 2K2C rats while their levels were down -regulated with drugs given.Conclusion The Nox4 involves in myocardial fibrosis regulated by TGF -β1 and CTGF in renovascular hypertensive rats.Atorvastatin may attenuate myocardial fibrosis of 2K2C rats and improve their cardiac function , the inhibition of TGF-β1/Nox4/CTGF pathway possibly contributes to these effects.
出处 《中国临床药理学杂志》 CAS CSCD 北大核心 2014年第7期594-596,606,共4页 The Chinese Journal of Clinical Pharmacology
基金 河南省教育厅自然科学基金资助项目(2010B310004) 河南科技大学创新能力培育基金资助项目(2009CZ0008)
关键词 肾性高血压 心肌纤维化 NAD( P) H氧化酶 结缔组织生长因子 阿托伐他汀 renovascular hypertension myocardial fibrosis NAD ( P ) H oxidases connective tissue growth factor atorvastatin
  • 相关文献

参考文献9

  • 1Blom IE, Goldschmeding R, Leask A, et al. Gene regulation of con- nective tissue growth factor:new targets for antifibrotic therapy [ J ]. Matrix Biol , 2002,21:473 -452.
  • 2Leask A, Holmes A, Abraham DJ, et al. Connective tissue growth factor : a new and important player in the pathogensis of fibrosis [ J ]. Curt Rheumatol Res, 2002,4:136 - 142.
  • 3Cucoranu I, Clempus R, Dikalova A, et al. NAD(P) H oxidase 4 medi- ates transforming gTowth factor - β1 - induced differentiation of cardiac fibmblasts into myofibreblasts [ J ]. Circ Res, 2005,97:900-907.
  • 4Zhao XY, Li L, Zhang JY, et al. Atorvastatin prevents left ventricu- lar remodeling in spontaneously hypertensive rats [ J ]. Int Heart J, 2010,51:426 -431.
  • 5曹珊珊,李瑞芳,方伟进,王建刚,李艳,张博.组蛋白去乙酰化酶8对肾性高血压大鼠心肌肥大的影响[J].中国病理生理杂志,2012,28(2):253-257. 被引量:7
  • 6Wang P, Tang F, Li R, et al. Contribution of different Nox homologues to cardiac remodeling in two - kidney two - clip renovascular hyperten- sive rats:effect of valsartan [J]. Pharmacol Res, 2007,55:408 -417.
  • 7Kuroda J, Ago T, Matsushima S, et al. NADPH oxidase 4 (Nox4) is a major source of oxidative stress in the failing heart [ J ]. Med Sci, 2010,107:5565 - 5570.
  • 8Bondi CD, Manickam N, Lee D, et al. NAD(P)H oxidase mediates TGF - betal - induced activation of kidney myofibroblasts [ J ]. J Am Soc Nephrol, 2010,21:93 - 102.
  • 9Ago T, Kuroda J, Pain J, et al. Upregulation of Nox4 by hypertrophic stimulipremotes apoptosis and mitochondrial dysfunction in cardiac myo- cytes [J]. Circ Res, 2010,106:1253 -1264.

二级参考文献11

  • 1Gallo P,Latronico MV,Gallo P,et al.Inhibition of class I histone deacetylase with an apicidin derivative prevents cardiac hypertrophy and failure[J].Cardiovasc Res,2008,80(3):416-424.
  • 2Nasrin N,Kaushik VK,Fortier E,et al.JNK1 phosphorylates SIRT1 and promotes its enzymic activity[J].PLoS One,2009,4(12):e8414.
  • 3Kee HJ,Kook H.Roles and targets of class Ⅰand Ⅱa histone deacetylases in cardiac hypertrophy[J].J Biomed Biotechnol,2011,2011:928326.
  • 4Ago T,Liu T,Zhai P,et al.A redox-dependent pathway for regulating class II HDACs and cardiac hypertrophy[J].Cell,2008,133(6):978-993.
  • 5Cho YK,Eom GH,Kee HJ,et al.Sodium valproate,a histone deacetylase inhibitor but not captopril prevents right ventricular hypertrophy in rats[J].Circ J,2010,74(4):760-770.
  • 6Kee HJ,Sohn IS,Nam KI,et al.Inhibition of histone deacetylation blocks cardiac hypertrophy induced by angiotensin II infusion and aortic banding[J].Circulation,2006,113(1):51-59.
  • 7Lu Y,Yang S.AngiotensinⅡinduces cardiomyocyte hypertrophy probably through histone deacetylases[J].Tohoku J Exp Med,2009,219(1):17 -23.
  • 8Kr(a)mer OH.HDAC2:a critical factor in health and disease[J].Trends Pharmacol Sci,2009,30(12):647-655.
  • 9李瑞芳,乐康,高洁,杨国庆,鲍颖霞,刘培庆.抑制PPAR-α表达对ET-1诱导的心肌肥大和PI3K/Akt/GSK3β-NFATc4通路的影响[J].中国病理生理杂志,2009,25(12):2289-2294. 被引量:10
  • 10席玉慧,孟庆威,徐长庆,王丽娜,林岩,李鸿珠,张力.Sirt1参与异丙肾上腺素诱导的小鼠心肌肥大[J].中国病理生理杂志,2010,26(5):844-847. 被引量:4

共引文献6

同被引文献42

引证文献6

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部